Almrud Jeffrey J, Kern Andrew D, Wang Susan C, Czerwinski Robert M, Johnson William H, Murzin Alexey G, Hackert Marvin L, Whitman Christian P
Department of Chemistry and Biochemistry, Division of Medicinal Chemistry, College of Pharmacy, The University of Texas, Austin, TX 78712-1071, USA.
Biochemistry. 2002 Oct 8;41(40):12010-24. doi: 10.1021/bi020271h.
The tautomerase superfamily consists of three major families represented by 4-oxalocrotonate tautomerase (4-OT), 5-(carboxymethyl)-2-hydroxymuconate isomerase (CHMI), and macrophage migration inhibitory factor (MIF). The members of this superfamily are structurally homologous proteins constructed from a simple beta-alpha-beta fold that share a key mechanistic feature; they use an amino-terminal proline, which has an unusually low pK(a), as the general base in a keto-enol tautomerization. Several new members of the 4-OT family have now been identified using PSI-BLAST and categorized into five subfamilies on the basis of multiple-sequence alignments and the conservation of key catalytic and structural residues. The members of subfamily 5, which includes a hypothetical protein designated YdcE from Escherichia coli, are predicted not to form hexamers. The crystal structure of YdcE has been determined to 1.35 A resolution and confirms that it is a dimer. In addition, YdcE complexed with (E)-2-fluoro-p-hydroxycinnamate, identified as a potent competitive inhibitor of this enzyme, as well as N-(2-hydroxyethyl)piperazine-N'-2-ethanesulfonic acid (HEPES) and benzoate are also presented. These latter crystal structures reveal the location of the active site and suggest a mechanism for the observed YdcE-catalyzed tautomerization reaction. The dimeric arrangement of YdcE represents a new structure in the 4-OT family and demonstrates structural diversity within the 4-OT family not previously reported.
互变异构酶超家族由三个主要家族组成,分别以4-草酰巴豆酸互变异构酶(4-OT)、5-(羧甲基)-2-羟基粘康酸异构酶(CHMI)和巨噬细胞迁移抑制因子(MIF)为代表。这个超家族的成员是由简单的β-α-β折叠构建而成的结构同源蛋白,它们具有一个关键的机制特征;它们使用氨基末端的脯氨酸(其pK(a)异常低)作为酮-烯醇互变异构中的通用碱。现在已经使用PSI-BLAST鉴定出了4-OT家族的几个新成员,并根据多序列比对以及关键催化和结构残基的保守性将它们分为五个亚家族。亚家族5的成员,包括来自大肠杆菌的一个假定蛋白YdcE,预计不会形成六聚体。已确定YdcE的晶体结构分辨率为1.35 Å,并证实它是一个二聚体。此外,还展示了与(E)-2-氟-对羟基肉桂酸(被鉴定为该酶的有效竞争性抑制剂)、N-(2-羟乙基)哌嗪-N'-2-乙烷磺酸(HEPES)和苯甲酸复合的YdcE。这些后面的晶体结构揭示了活性位点的位置,并提出了观察到的YdcE催化的互变异构反应的机制。YdcE的二聚体排列代表了4-OT家族中的一种新结构,并证明了4-OT家族中以前未报道的结构多样性。